Dimensional Fund Advisors LP Merrimack Pharmaceuticals Inc Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 09, 2024	SELL	$14.68 - $15.13 $1.16 Million - $1.2 Million	-79,006 Reduced 19.85%	318,995 $4.83 Million
Q1 2024 May 10, 2024	SELL	$13.06 - $15.0 $491,630 - $564,660	-37,644 Reduced 8.64%	398,001 $5.88 Million
Q4 2023 Feb 07, 2024	SELL	$12.02 - $13.41 $157,546 - $175,764	-13,107 Reduced 2.92%	435,645 $5.84 Million
Q3 2023 Nov 09, 2023	SELL	$11.6 - $12.52 $130,012 - $140,324	-11,208 Reduced 2.44%	448,752 $5.53 Million
Q2 2023 Aug 09, 2023	SELL	$12.02 - $13.07 $74,283 - $80,772	-6,180 Reduced 1.33%	459,960 $5.66 Million
Q1 2023 May 12, 2023	SELL	$11.35 - $12.32 $59,394 - $64,470	-5,233 Reduced 1.11%	466,140 $5.73 Million
Q4 2022 Feb 09, 2023	SELL	$3.68 - $12.51 $3,415 - $11,609	-928 Reduced 0.2%	471,373 $5.4 Million
Q3 2022 Nov 10, 2022	SELL	$3.7 - $6.06 $16,305 - $26,706	-4,407 Reduced 0.92%	472,301 $1.77 Million
Q2 2022 Aug 12, 2022	SELL	$4.89 - $7.13 $28,244 - $41,182	-5,776 Reduced 1.2%	476,708 $2.84 Million
Q1 2022 May 13, 2022	SELL	$3.75 - $6.82 $23,261 - $42,304	-6,203 Reduced 1.27%	482,484 $3.05 Million
Q4 2021 Feb 09, 2022	SELL	$3.75 - $5.1 $40,053 - $54,473	-10,681 Reduced 2.14%	488,687 $1.91 Million
Q3 2021 Nov 12, 2021	SELL	$4.3 - $6.39 $78,591 - $116,790	-18,277 Reduced 3.53%	499,368 $2.41 Million
Q2 2021 Aug 12, 2021	SELL	$6.04 - $7.77 $9,513 - $12,237	-1,575 Reduced 0.3%	517,645 $3.31 Million
Q1 2021 May 14, 2021	SELL	$6.15 - $8.7 $192,611 - $272,475	-31,319 Reduced 5.69%	519,220 $3.26 Million
Q4 2020 Feb 25, 2021	BUY	$3.69 - $8.31 $2.03 Million - $4.57 Million	550,539 New	550,539 $3.79 Million

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.